Codiak BioSciences Receives $61,000,000 Series B Financing Round

  • Feed Type
  • Date
    1/26/2016
  • Company Name
    Codiak BioSciences
  • Mailing Address
    19 Presidential Way Woburn, MA 081801 USA
  • Company Description
    Codiak Biosciences is developing exosomes, natural vesicles that mediate inter-cellular communication, as both a powerful therapeutic modality and an advanced diagnostic system.
  • Website
    http://www.codiakbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $61,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    With these additional resources we will continue to build our world-class team to realize the broad transformative potential of exosomes for multiple therapeutic and diagnostic uses. Codiak intends to use the proceeds of this round primarily to advance research and clinical development of exosomes for therapeutic and diagnostic purposes.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Alexandria Venture Investments
  • Venture Investor
    Alaska Permanent Fund
  • Venture Investor
    Fidelity Management & Research Company

Trending on Xconomy